1. Home
  2. VABK vs CABA Comparison

VABK vs CABA Comparison

Compare VABK & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$40.50

Market Cap

215.8M

Sector

Finance

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.75

Market Cap

212.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
CABA
Founded
1998
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.8M
212.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
VABK
CABA
Price
$40.50
$2.75
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$14.57
AVG Volume (30 Days)
5.8K
4.0M
Earning Date
01-23-2026
11-10-2025
Dividend Yield
3.63%
N/A
EPS Growth
14.22
N/A
EPS
3.30
N/A
Revenue
$56,512,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.01
N/A
Revenue Growth
10.39
N/A
52 Week Low
$34.12
$0.99
52 Week High
$44.57
$3.67

Technical Indicators

Market Signals
Indicator
VABK
CABA
Relative Strength Index (RSI) 51.19 57.81
Support Level $39.10 $2.04
Resistance Level $40.43 $3.34
Average True Range (ATR) 0.63 0.22
MACD 0.04 0.08
Stochastic Oscillator 65.12 54.23

Price Performance

Historical Comparison
VABK
CABA

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: